ICAM1 and Alzheimer disease: These findings revealed for the first time that the AD-typical chronic neuroinflammation can be advanced by the NAHAs’ Aβ•CaSR signaling-elicited secretion of proinflammatory cytokine IL-6, chemokines RANTES and MCP-2, and of the s-ICAM-1 fragment.